Holen Sie sich die Stockscreener-App
3.17
0.31%
-0.01
Handel nachbörslich:
3.17
Schlusskurs vom Vortag:
$3.18
Offen:
$3.29
24-Stunden-Volumen:
3.02M
Relative Volume:
1.60
Marktkapitalisierung:
$514.92M
Einnahmen:
$400.57M
Nettoeinkommen (Verlust:
$9.21M
KGV:
79.25
EPS:
0.04
Netto-Cashflow:
$146.36M
1W Leistung:
-5.93%
1M Leistung:
+105.84%
6M Leistung:
+385.90%
1J Leistung:
-9.94%
1-Tages-Spanne:
$3.05
$3.44
1-Wochen-Bereich:
$2.96
$3.47
52-Wochen-Spanne:
$0.5271
$5.1288
Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile
Firmenname
Ironwood Pharmaceuticals Inc
Sektor
Telefon
617-621-7722
Adresse
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Vergleichen Sie IRWD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRWD
Ironwood Pharmaceuticals Inc
|
3.17 | 517.32M | 400.57M | 9.21M | 146.36M | 0.04 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-15 | Herabstufung | Jefferies | Buy → Hold |
| 2025-04-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-04-14 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-09-09 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-08-08 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2024-01-17 | Eingeleitet | Craig Hallum | Buy |
| 2023-12-14 | Eingeleitet | Wells Fargo | Overweight |
| 2023-11-09 | Eingeleitet | Jefferies | Buy |
| 2023-09-28 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-09-02 | Eingeleitet | CapitalOne | Overweight |
| 2022-04-22 | Eingeleitet | Piper Sandler | Overweight |
| 2020-09-30 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-06-17 | Eingeleitet | Northland Capital | Outperform |
| 2019-07-10 | Fortgesetzt | Credit Suisse | Neutral |
| 2019-03-27 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2019-02-25 | Hochstufung | H.C. Wainwright | Sell → Neutral |
| 2019-01-24 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-11-07 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-11-07 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-07-23 | Eingeleitet | H.C. Wainwright | Sell |
| 2018-05-09 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-01-05 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2017-12-06 | Herabstufung | Mizuho | Buy → Neutral |
| 2017-07-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-05-03 | Eingeleitet | Wells Fargo | Outperform |
| 2017-04-07 | Bestätigt | Mizuho | Buy |
| 2017-02-22 | Bestätigt | Barclays | Equal Weight |
| 2016-11-04 | Bestätigt | Mizuho | Buy |
| 2016-10-24 | Bestätigt | Wedbush | Neutral |
| 2016-10-10 | Bestätigt | Mizuho | Buy |
| 2016-09-27 | Bestätigt | WallachBeth | Hold |
Alle ansehen
Ironwood Pharmaceuticals Inc Aktie (IRWD) Neueste Nachrichten
How Ironwood Pharmaceuticals Inc. stock benefits from strong dollarJuly 2025 Volume & Free Technical Confirmation Trade Alerts - newser.com
How Ironwood Pharmaceuticals Inc. (I76) stock trades under stagflationInsider Buying & Technical Entry and Exit Tips - newser.com
Is Ironwood Pharmaceuticals Inc. (I76) stock attractive for dividend growthJuly 2025 Review & Capital Protection Trading Alerts - newser.com
How Ironwood Pharmaceuticals Inc. stock compares to industry benchmarksWeekly Trade Recap & Low Risk Profit Maximizing Plans - newser.com
Is Ironwood Pharmaceuticals Inc. stock a dividend growth opportunityMarket Growth Report & Smart Allocation Stock Tips - newser.com
How Ironwood Pharmaceuticals Inc. (I76) stock moves on employment dataPortfolio Return Summary & Real-Time Volume Analysis Alerts - newser.com
Can Ironwood Pharmaceuticals Inc. (I76) stock deliver strong annual returnsWeekly Volume Report & AI Forecast for Swing Trade Picks - newser.com
Can Ironwood Pharmaceuticals Inc. stock deliver strong Q4 earningsMarket Sentiment Summary & Fast Moving Stock Trade Plans - newser.com
Will earnings trigger a reversal in Ironwood Pharmaceuticals Inc.2025 Price Momentum & AI Enhanced Trading Signals - newser.com
Will Ironwood Pharmaceuticals Inc. stock outperform Dow Jones indexJuly 2025 Earnings & Safe Swing Trade Setups - newser.com
Will breakout in Ironwood Pharmaceuticals Inc. lead to full recoveryMarket Activity Report & Real-Time Market Trend Scan - newser.com
Can Ironwood Pharmaceuticals Inc. stock continue upward trendDip Buying & Intraday High Probability Setup Alerts - newser.com
Price momentum metrics for Ironwood Pharmaceuticals Inc. explainedQuarterly Portfolio Report & Safe Investment Capital Preservation Plans - newser.com
Will Ironwood Pharmaceuticals Inc. outperform the marketWeekly Investment Report & Free Growth Oriented Trading Recommendations - newser.com
What is the fair value of Ironwood Pharmaceuticals Inc. stock nowWeekly Profit Report & Daily Growth Stock Investment Tips - newser.com
Published on: 2025-11-18 19:33:35 - newser.com
What’s next for Ironwood Pharmaceuticals Inc. stock priceTrade Volume Report & Fast Momentum Stock Entry Tips - newser.com
Will Ironwood Pharmaceuticals Inc. stock maintain dividend yieldPortfolio Profit Report & Reliable Price Breakout Alerts - newser.com
Live market analysis of Ironwood Pharmaceuticals Inc.Earnings Risk Summary & Reliable Price Breakout Signals - newser.com
Why Ironwood Pharmaceuticals Inc. (I76) stock could be next leaderDollar Strength & Weekly Setup with ROI Potential - newser.com
Ironwood Pharmaceuticals (IRWD) Price Target Increased by 89.47% to 1.84 - Nasdaq
Finanzdaten der Ironwood Pharmaceuticals Inc-Aktie (IRWD)
Umsatz
Nettogewinn
Free Cashflow
ENV
6.17%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):